Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM50208911![]() (CHEMBL3884319) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 206 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck & Co. Curated by ChEMBL | Assay Description Inhibition of human recombinant full length N-terminal GST/N-terminal His-tagged AMPK alpha2/beta1/gamma1 expressed in baculovirus expression system | Bioorg Med Chem Lett 27: 114-120 (2017) Article DOI: 10.1016/j.bmcl.2016.08.068 BindingDB Entry DOI: 10.7270/Q2N018JC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM50537742![]() (CHEMBL4634634 | US11179389, Compound 1-14) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck & Co. Curated by ChEMBL | Assay Description Inhibition of neuraminidase of influenza A/PR/8/34(H1N1) | Bioorg Med Chem Lett 30: (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213186![]() (US9290517, 14) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 29 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213187![]() (US9290517, 18) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213188![]() (US9290517, 71) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213189![]() (US9290517, 73) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213190![]() (US9290517, 79) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213191![]() (US9290517, 86) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213192![]() (US9290517, 87) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213193![]() (US9290517, 102) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213194![]() (US9290517, 105) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213195![]() (US9290517, 125) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213196![]() (US9290517, 126) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213197![]() (US9290517, 127) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213198![]() (US9290517, 128) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213199![]() (US9290517, 129) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213200![]() (US9290517, 130) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213201![]() (US9290517, 131) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213202![]() (US9290517, 133) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213203![]() (US9290517, 138) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213204![]() (US9290517, 142) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213205![]() (US9290517, 145) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213206![]() (US9290517, 146) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213207![]() (US9290517, 147) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213208![]() (US9290517, 149) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213209![]() (US9290517, 150) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM213210![]() (US9290517, 151) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | 7.3 | n/a |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat... | US Patent US9290517 (2016) BindingDB Entry DOI: 10.7270/Q2C24V7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260428![]() (US9527839, 6) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260429![]() (US9527839, 7) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260430![]() (US9527839, 8) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 12 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260431![]() (US9527839, 16) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260432![]() (US9527839, 18) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 14 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260433![]() (US9527839, 19) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 15 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260434![]() (US9527839, 21) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260435![]() (US9527839, 23) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 18 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260436![]() (US9527839, 24) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 18 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260439![]() (US9527839, 35) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260440![]() (US9527839, 36) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260441![]() (US9527839, 38) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 17 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260442![]() (US9527839, 39) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260443![]() (US9527839, 40) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260444![]() (US9527839, 42) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260445![]() (US9527839, 43) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260446![]() (US9527839, 44) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 11 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260447![]() (US9527839, 45) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260448![]() (US9527839, 47) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260449![]() (US9527839, 48) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260450![]() (US9527839, 49) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM260451![]() (US9527839, 50) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp US Patent | Assay Description The in vitro AMPK activation assay is performed in a volume of 30 ul in a 384-well plate. Enzyme reactions were assembled in the microtiter plate by ... | US Patent US9527839 (2016) BindingDB Entry DOI: 10.7270/Q2N58K9B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK alpha2/beta1/gamma1 (Homo sapiens (Human)) | BDBM237920![]() (US9394285, 1) | PDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia antibodypedia GoogleScholar | Purchase PC cid PC sid PDB UniChem | PDB Article PubMed | n/a | n/a | n/a | n/a | 6.80 | n/a | n/a | n/a | n/a |
Pfizer Inc Curated by ChEMBL | Assay Description Activation of recombinant human AMPK alpha2/beta1/gamma1 using Cy5-labelled SAMS as substrate assessed as protection from Thr172 residue dephosphoryl... | J Med Chem 59: 8068-81 (2016) Article DOI: 10.1021/acs.jmedchem.6b00866 BindingDB Entry DOI: 10.7270/Q2PZ5BRC | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) |
Displayed 1 to 50 (of 127 total ) | Next | Last >> |